Suppr超能文献

服用 Ashwagandha 补充剂对焦虑和压力的管理是否有有益的影响?随机对照试验的系统评价和荟萃分析。

Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials.

机构信息

Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.

Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Phytother Res. 2022 Nov;36(11):4115-4124. doi: 10.1002/ptr.7598. Epub 2022 Aug 25.

Abstract

Clinical trial studies revealed conflicting results on the effect of Ashwagandha extract on anxiety and stress. Therefore, we aimed to evaluate the effect of Ashwagandha supplementation on anxiety as well as stress. A systematic search was performed in PubMed/Medline, Scopus, and Google Scholar from inception until December 2021. We included randomized clinical trials (RCTs) that investigate the effect of Ashwagandha extract on anxiety and stress. The overall effect size was pooled by random-effects model and the standardized mean difference (SMD) and 95% confidence interval (CIs) for outcomes were applied. Overall, 12 eligible papers with a total sample size of 1,002 participants and age range between 25 and 48 years were included in the current systematic review and meta-analysis. We found that Ashwagandha supplementation significantly reduced anxiety (SMD: -1.55, 95% CI: -2.37, -0.74; p = .005; I  = 93.8%) and stress level (SMD: -1.75; 95% CI: -2.29, -1.22; p = .005; I  = 83.1%) compared to the placebo. Additionally, the non-linear dose-response analysis indicated a favorable effect of Ashwagandha supplementation on anxiety until 12,000 mg/d and stress at dose of 300-600 mg/d. Finally, we identified that the certainty of the evidence was low for both outcomes. The current systematic review and dose-response meta-analysis of RCTs revealed a beneficial effect in both stress and anxiety following Ashwagandha supplementation. However, further high-quality studies are needed to firmly establish the clinical efficacy of the plant.

摘要

临床试验研究结果显示,关于 Ashwagandha 提取物对焦虑和压力的影响存在相互矛盾的结果。因此,我们旨在评估 Ashwagandha 补充剂对焦虑和压力的影响。我们在 PubMed/Medline、Scopus 和 Google Scholar 中进行了系统搜索,检索时间从建库开始至 2021 年 12 月。我们纳入了研究 Ashwagandha 提取物对焦虑和压力影响的随机临床试验(RCT)。采用随机效应模型汇总总体效应量,应用标准化均数差(SMD)和 95%置信区间(CI)评估结局。总体上,纳入了 12 项符合条件的研究,共有 1002 名参与者,年龄在 25 至 48 岁之间,这些研究被纳入本次系统评价和荟萃分析。我们发现,与安慰剂相比,Ashwagandha 补充剂显著降低了焦虑(SMD:-1.55,95%CI:-2.37,-0.74;p =.005;I² = 93.8%)和压力水平(SMD:-1.75;95%CI:-2.29,-1.22;p =.005;I² = 83.1%)。此外,非线性剂量-反应分析表明,Ashwagandha 补充剂在 12000mg/d 剂量下对焦虑具有有利影响,在 300-600mg/d 剂量下对压力具有有利影响。最后,我们发现这两个结局的证据确定性都较低。本 RCT 的系统评价和剂量-反应荟萃分析显示,Ashwagandha 补充剂可改善焦虑和压力。然而,需要进一步开展高质量研究来明确该植物的临床疗效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验